Burimamide
Thiourea
A photographic fixative used also in the manufacture of resins. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance may reasonably be anticipated to be a carcinogen (Merck Index, 9th ed). Many of its derivatives are ANTITHYROID AGENTS and/or FREE RADICAL SCAVENGERS.
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.
Tripelennamine
Histamine
Receptors, Histamine
Cell-surface proteins that bind histamine and trigger intracellular changes influencing the behavior of cells. Histamine receptors are widespread in the central nervous system and in peripheral tissues. Three types have been recognized and designated H1, H2, and H3. They differ in pharmacology, distribution, and mode of action.
Histamine Antagonists
Receptors, Histamine H3
A class of histamine receptors discriminated by their pharmacology and mode of action. Histamine H3 receptors were first recognized as inhibitory autoreceptors on histamine-containing nerve terminals and have since been shown to regulate the release of several neurotransmitters in the central and peripheral nervous systems. (From Biochem Soc Trans 1992 Feb;20(1):122-5)
Methylhistamines
Pyrilamine
Receptors, Histamine H2
A class of histamine receptors discriminated by their pharmacology and mode of action. Histamine H2 receptors act via G-proteins to stimulate ADENYLYL CYCLASES. Among the many responses mediated by these receptors are gastric acid secretion, smooth muscle relaxation, inotropic and chronotropic effects on heart muscle, and inhibition of lymphocyte function. (From Biochem Soc Trans 1992 Feb;20(1):122-5)
Receptors, Drug
Imidazoles
An indirect sympathomimetic effect of burimamide on kitten isolated atria. (1/24)
1. Burimamide (34-1080 muM) caused a concentration-dependent increase in the force and frequency of contraction of kitten isolated atria. 2. Metiamide (467 muM) had no stimulant action on kitten atria and did not modify the effects of burimamide. 3. The atrial stimulation produced by burimamide was reduced by (-)propranolol (34-68 nM) and by cocaine (3 muM). 4. The atrial stimulant effect of burimamide was prevented by pretreatment of kittens with reserpine (1 mg/kg, 24 h before the experiment). 5. It is concluded that burimamide causes atrial stimulation by releasing catecholamines. (+info)Constitutive activity of histamine h(3) receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H(3) antagonists. (2/24)
Agonist-independent activity of G-protein-coupled receptor, also referred to as constitutive activity, is a well-documented phenomenon and has been reported recently for both the histamine H(1) and H(2) receptors. Using SK-N-MC cell lines stably expressing the human and rat H(3) receptors at physiological receptor densities (500-600 fmol/mg of protein), we show that both the rat and human H(3) receptors show a high degree of constitutive activity. The forskolin-mediated cAMP production in SK-N-MC cells is inhibited strongly upon expression of the G(i)-coupled H(3) receptor. The cAMP production can be further inhibited upon agonist stimulation of the H(3) receptor and can be enhanced by a variety of H(3) antagonists acting as inverse agonists at the H(3) receptor. Thioperamide, clobenpropit, and iodophenpropit raise the cAMP levels in SK-N-MC cells with potencies that match their receptor binding affinities. Surprisingly, impentamine and burimamide act as effective H(3) agonists. Modification of the amine group of impentamine dramatically affected the pharmacological activity of the ligand. Receptor affinity was reduced slightly for most impentamine analogs, but the functional activity of the ligands varied from agonist to neutral antagonist and inverse agonist, indicating that subtle changes in the chemical structures of impentamine analogs have major impact on the (de)activation steps of the H(3) receptor. In conclusion, upon stable expression of the rat and human H(3) receptor in SK-N-MC cells constitutive receptor activity is detected. In this experimental system, H(3) receptors ligands, previously identified as H(3) antagonists, cover the whole spectrum of pharmacological activities, ranging from full inverse agonists to agonists. (+info)The role of H1 and H2-receptors in the coronary vascular response to histamine of isolated perfused hearts of guinea-pigs and rabbits. (3/24)
1. The effects of histamine on the isolated perfused hearts of guinea-pigs and rabbits were examined. Records of contractile force, heart rate and coronary perfusion pressure were obtained. 2. Histamine exerted positive inotropic and chronotropic effects which were antagonized by burimamide and attributed to stimulation of H2-receptors. 3. The coronary vascular response to histamine differed between guinea-pigs and rabbits. In guinea-pig hearts, three phases were apparent: (a) An initial vasodilatation preceding any effects on heart force and rate was antagonized by mepyramine and therefore mediated by histamine H1-receptors in the coronary circulation. (b) A secondary vasoconstriction was attributed to the increased myocardial compression during the positive inotropic and chronotropic responses. (c) The final, more predominant, component was a prolonged vasodilatation probably associated with the increased metabolic activity of the heart. 4. The latter two components were abolished together with the myocardial responses by burimamide. The remaining coronary vascular response was biphasic, consisting of a vasodilatation immediately followed by vasoconstriction. Both were antagonized by mepyramine and therefore mediated by H1-receptors. 5. The coronary vascular response of rabbit hearts was similar but no direct vasodilatation was observed and it was concluded that histamine receptors in the coronary vasculature involve only vasoconstriction. (+info)Inhibition of sympathetic hypertensive responses in the guinea-pig by prejunctional histamine H3-receptors. (4/24)
1. The effect of (R)-alpha-methylhistamine, a selective H3-histamine receptor agonist, was examined on the neurogenic hypertension and tachycardia that is induced by stimulation of areas in the medulla oblongata of guinea-pigs. Electrical medullary stimulation (32 Hz, 3-5 s trains, 0.5-1.0 ms square pulse, 25-400 microA) produced intensity-dependent increases in blood pressure and a more variable tachycardia. 2. (R)-alpha-methylhistamine inhibited the hypertension and tachycardia due to submaximal CNS stimulation. The inhibition of hypertension by (R)-alpha-methylhistamine was dose-dependent (10-300 micrograms kg-1, i.v.) and was not seen at high intensities of stimulation. 3. (R)-alpha-methylhistamine (300 micrograms kg-1, i.v.) did not attenuate the pressor response to adrenaline (1 and 3 micrograms kg-1, i.v.), indicating that the effect of (R)-alpha-methylhistamine was not mediated by a postjunctional action on smooth muscle. 4. The inhibition of CNS-induced hypertension by (R)-alpha-methylhistamine (300 micrograms kg-1, i.v.) was blocked by the H3 antagonists, thioperamide (ID50 = 0.39 mg kg-1, i.v.), impromidine (ID50 = 0.22 mg kg-1, i.v.) and burimamide (ID50 = 6 mg kg-1, i.v.). The rank order potency of these antagonists is consistent with activity at the H3B receptor subtype. Chlorpheniramine (30 micrograms kg-1, i.v.) and cimetidine (3 mg kg-1, i.v.) did not antagonize the inhibition of CNS-hypertension by (R)-alpha-methylhistamine. 5. These results suggest that (R)-alpha-methylhistamine inhibits sympathetic hypertensive responses in guinea-pigs by activation of prejunctional H3-receptors, possibly located on postganglionic nerve terminals. Furthermore, on the basis of the rank order potency to different H3-antagonists, it appears that the H3B-receptor subtype is involved with H3-receptor responses on vascular sympathetic nerves. (+info)Effects of the histamine H2-receptor blocking drugs burimamide and cimetidine on noradrenergic transmission in the isolated aorta of the rabbit and atria of the guinea-pig. (5/24)
1 In rabbit aortic strips, concentration-response curves to noradrenaline (NA) were shifted to the right in a parallel and concentration-dependent manner by the alpha-adrenoceptor blocking drug, phentolamine and also by the histamine H(2)-receptor blocking drugs, burimamide and cimetidine. Responses to 5-hydroxytryptamine were not affected by these drugs.2 Burimamide had the properties of a competitive antagonist of noradrenaline, possessing about one-hundredth the potency of phentolamine. Cimetidine was weaker than burimamide and did not fulfil the requirements for competitive antagonism of noradrenaline.3 In guinea-pig isolated atria, in which noradrenergic transmitter stores were labelled with [(3)H]-noradrenaline, phentolamine (3 muM), burimamide (30 muM) and cimetidine (30 muM), in decreasing order of effectiveness, each enhanced stimulation-induced efflux of [(3)H]-noradrenaline, indicating that their blocking effects on prejunctional alpha-adrenoceptors in this tissue are in the same order of relative potency as on postjunctional alpha-adrenoceptors in rabbit aortic strips.4 In the concentrations used (30 muM), neither burimamide nor cimetidine interfered with the neuronal uptake of noradrenaline. Burimamide, and to a much lesser extent, cimetidine, increased the resting efflux of [(3)H]-noradrenaline from guinea-pig atria.5 The effect of clonidine, a partial agonist on prejunctional alpha-adrenoceptors in guinea-pig atria, in increasing stimulation-induced efflux of [(3)H]-noradrenaline when stimulated with 150 pulses at 5 Hz was blocked by cimetidine (30 muM) and reversed by phentolamine (3 muM) and burimamide (30 muM). (+info)The effects of burimamide and metiamide on basal gastric function in the cat. (6/24)
1 Burimamide injected intravenously in the anaesthetized or conscious cat produced significant increases in gastric acid secretion: in the anaesthetized cat it produced increased gastric mucosal blood flow. 2 Metiamide, in doses which inhibited pentagastrin-stimulated acid secretion, produced no increase in gastric acid secretion in conscious animals, or gastric acid secretion or gastric mucosal blood flow in the anaesthetized cat. 3 Metiamide did not influence the amount of acid which diffused out of the stomach when instilled at pH values between 1.5 and 6.0. 4 The possible mode of action of burimamide in increasing basal gastric secretion is discussed. (+info)Interaction of histamine H1-and H2-receptor antagonists with histamine uptake and metabolism by guinea-pig isolated atrium and mouse neoplastic mast cells cells in vitro. (7/24)
1. Burimamide, metiamide, chlorpheniramine, triprolidine and cocaine, were tested as inhibitors of histamine uptake and metabolism in the guinea-pig atrium and in mouse neoplastic mast cells. 2. Cocaine did not affect the uptake and metabolism of histamine, either in the atrium or in the mast cells. All the antihistamines tested blocked the uptake and metabolism of histamine in both preparations. The order of potency was burimamide greater than chlorpheniramine greater than triprolidine greater than metiamide in the atrium; and burimamide greater than metiamide greater than triprolidine greater than chlorpheniramine, in the mase cells. 3. Comparison of the present results with the antihistamine activity of these blocking agents suggests that no correlation exists between the receptor blocking activity and the ability of these substances to act as inhibitors of histamine uptake and metabolism. (+info)The possible roles of histamine, 5-hydroxytryptamine and prostaglandin F2alpha as mediators of the acute pulmonary effects of endotoxin. (8/24)
1 In an attempt to investigate the possible role of released vasoactive substances in mediating the pulmonary pressor responses to E. coli endotoxin, cats were pretreated with histamine, 5-hydroxytryptamine (5-HT) or prostaglandin antagonists, with a histamine depleting agent (compound 48/80) or with an inhibitor of prostaglandin synthetase (sodium meclofenamate).2 The administration of endotoxin (2 mg/kg) resulted in a rapidly developing pulmonary hypertension (pressure twice normal after 2-3 min), increases in right atrial and intratracheal pressures, systemic hypotension and bradycardia. These effects were unaffected by methysergide in a dose sufficient to prevent the effects of intravenously administered 5-HT.3 Endotoxin responses were also unaffected by a combination of mepyramine and burimamide in doses sufficient to reduce markedly the effects of intravenously-administered histamine. In cats pretreated (chronically or acutely) with compound 48/80, endotoxin induced a transient pulmonary pressor response which was not maintained.4 The pulmonary and systemic responses to endotoxin were prevented by the prior administration of the prostaglandin antagonist, polyphloretin phosphate and by pretreatment with the prostaglandin synthetase inhibitor, sodium meclofenamate.5 It is concluded that a pulmonary vasoconstrictor prostaglandin is involved in the acute response to endotoxin in the cat. (+info)
Specific inhibition by burimamide of histamine effects on myocardial contraction and cyclic AMP | SpringerLink
Escalando uma plataforma poliglota: a arquitetura de vídeos online da Globo.com
Plus it
Sensory responses of human skin to synthetic histamine analogues and histamine
ベタヒスチン and breastfeeding. Are they compatible?
Tab. Verbet-16mg | Histamine analogue OTC | Online Pharmacy in Nepal
Effect of metiamide on basal and stimulated serum cholecystokinin levels in duodenal ulcer patients. | Gut
Burimamide
... is an antagonist at the H2 and H3 histamine receptors. It is largely inactive as an H2 antagonist at physiological ... Burimamide was first developed by scientists at Smith, Kline & French (SK&F; now GlaxoSmithKline) in their intent to develop a ... The discovery of burimamide ultimately led to the development of cimetidine (Tagamet). Metiamide Cimetidine Clayden, Jonathan; ...
H2 receptor antagonist
Burimamide is 100 times more potent than Nα-guanylhistamine, proving its efficacy on the H2 receptor. The potency of burimamide ... From this lead, the receptor model was further refined, which eventually led to the development of burimamide, a specific ...
C. Robin Ganellin
However, it was soon realised that burimamide was not an appropriate oral medicine. They quickly identified a similar drug, ... The end result of their trials was cimetidine, an H2-receptor antagonist superior to both burimamide and metiamide. The ... Initially, the team developed burimamide as a potential H2-receptor antagonist for medicinal use. ...
Metiamide
... is a histamine H2 receptor antagonist developed from another H2 antagonist, burimamide. It was an intermediate ... the following steps were undertaken to stabilize burimamide: addition of a sulfide group close to the imidazole ring, giving ... to the H2 receptor These changes increased the bioavailability metiamide so that it is ten times more potent than burimamide in ... compound in the development of the successful anti-ulcer drug cimetidine (Tagamet). After discovering that burimamide is ...
Chemoreceptor trigger zone
... burimamide and metiamide. Recent studies have found that phosphodiesterase 4 (PDE4) inhibitors, such as Rolipram, cause emesis ...
Cimetidine
Burimamide, a specific competitive antagonist at the H2 receptor, 100 times more potent than Nα-guanylhistamine, proved the ... Burimamide was still insufficiently potent for oral administration, and further modification of the structure, based on ... From this lead, the receptor model was further refined and eventually led to the development of burimamide, the first H2 ...
Histamine H3 receptor
Burimamide (also weak H2 antagonist) Ciproxifan Clobenpropit (also H4 antagonist) Conessine Failproxifan[citation needed] (No ...
List of MeSH codes (D02)
... burimamide MeSH D02.886.904.282 - dimaprit MeSH D02.886.904.365 - guanylthiourea MeSH D02.886.904.390 - isothiuronium MeSH ... burimamide MeSH D02.948.898.282 - dimaprit MeSH D02.948.898.323 - ethylenethiourea MeSH D02.948.898.365 - guanylthiourea MeSH ...
Histamine H3 receptor binding sites in rat brain membranes: modulations by guanine nucleotides and divalent cations
H₂-receptor antagonist
Burimamide, a specific competitive antagonist at the H2 receptor 100-times more potent than Nα-guanylhistamine, proved the ... From this lead the receptor model was further refined and eventually led to the development of burimamide - the first H2- ... Burimamide was still insufficiently potent for oral administration and further modification of the structure, based on ...
Target Selection in Drug Discovery | The Scientist Magazine®
DeCS
Ebastine - wikidoc
Ebastine is a second-generation H1 receptor antagonist that is indicated mainly for allergic rhinitis and chronic idiopathic urticaria.[4] It is available in 10 and 20 mg tablets[5] and as fast-dissolving tablets,[6] as well as in pediatric syrup. It has a recommended flexible daily dose of 10 or 20 mg, depending on disease severity. Ebastine is available in different formulations (tablets, fast dissolving tablets and syrup) and commercialized under different brand names around the world, Ebet, Ebastel FLAS, Kestine, KestineLIO, KestinLYO, EstivanLYO, Evastel Z, Ebatrol, etc. ...
Truvada And Muscle Cramps, How to order truvada buy hong kong / Bluepond
MeSH Browser
Perospirone - WikiProjectMed
In a clinical trial that compared it to haloperidol in the treatment of schizophrenia it was found to produce significantly superior overall symptom control.[5] In another clinical trial perospirone was compared with mosapramine and produced a similar reduction in total PANSS score, except with respect to the blunted affect part of the PANSS negative score, in which perospirone produced a significantly greater improvement.[6] In an open-label clinical trial comparing aripiprazole with perospirone there was no significant difference between the two treatments discovered in terms of both efficacy and tolerability.[7] In 2009 a clinical trial found that perospirone produced a similar reduction of PANSS score than risperidone and the extrapyramidal side effects was similar in both frequency and severity between groups.[8] A meta-analysis published in 2013 found that it is statistically significantly less efficacious than other second-generation antipsychotics.[9] ...
Orphenadrine
IMSEAR at SEARO: Search
MeSH Browser
Burimamide Preferred Term Term UI T005814. Date01/01/1999. LexicalTag NON. ThesaurusID ... Burimamide Preferred Concept UI. M0003056. Registry Number. TN5A4OD2TV. Related Numbers. 34970-69-9. Scope Note. An antagonist ... Burimamide. Tree Number(s). D02.065.950.898.200. D02.886.904.200. Unique ID. D002049. RDF Unique Identifier. http://id.nlm.nih. ...
Characterization and development of cimetidine as a histamine H2-receptor antagonist - PubMed
Constitutive Activity and Structural Instability of the Wild-type Human H2 receptor<...
Burimamide, a neutral antagonist at the rat H2 receptor, behaved as a weak partial agonist at the human H2 receptor. Burimamide ... Burimamide, a neutral antagonist at the rat H2 receptor, behaved as a weak partial agonist at the human H2 receptor. Burimamide ... Burimamide, a neutral antagonist at the rat H2 receptor, behaved as a weak partial agonist at the human H2 receptor. Burimamide ... Burimamide, a neutral antagonist at the rat H2 receptor, behaved as a weak partial agonist at the human H2 receptor. Burimamide ...
MeSH Browser
Burimamide Preferred Term Term UI T005814. Date01/01/1999. LexicalTag NON. ThesaurusID ... Burimamide Preferred Concept UI. M0003056. Registry Number. TN5A4OD2TV. Related Numbers. 34970-69-9. Scope Note. An antagonist ... Burimamide. Tree Number(s). D02.065.950.898.200. D02.886.904.200. Unique ID. D002049. RDF Unique Identifier. http://id.nlm.nih. ...
Desmethylclozapine - Wikipedia
N-Desmethylclozapine (NDMC), or norclozapine, is a major active metabolite of the atypical antipsychotic drug clozapine.[1][2] Unlike clozapine, it possesses intrinsic activity at the D2/D3 receptors, and acts as a weak partial agonist at these sites similarly to aripiprazole and bifeprunox.[3] Notably, NDMC has also been shown to act as a potent and efficacious agonist at the M1 and δ-opioid receptors, unlike clozapine as well.[4][5][6] It was hypothesized that on account of these unique actions, NDMC might underlie the clinical superiority of clozapine over other antipsychotics. However, clinical trials found NMDC itself ineffective in the treatment of schizophrenia.[7][8] This may be because it possesses relatively low D2/D3 occupancy compared to 5-HT2 (,15% versus 64-79% at a dose of 10-60 mg/kg s.c. in animal studies).[9] In any case, though not useful in the treatment of positive symptoms on its own, it cannot be ruled out that NDMC may contribute to the efficacy of clozapine on cognitive ...
Bio2Vec
DeCS
µ
rX Drugstore: Hochu viagra wiki drug treatment online!
NDF-RT Code NDF-RT Name
rX Drugstore: Viagra pct patent application 1994 delivery with insurance!
All About Heaven - Overload
Inhibition of gastric acidity secretion may be the mainstay of the - PI3K and Akt as molecular targets for cancer therapy
ABORTIFACIENT AGENTS ABORTIFACIENT AGENTS
ANTI-ULCER AGENTS BURIMAMIDE ANTI-ULCER AGENTS CALCIUM CARBONATE ANTI-ULCER AGENTS CARBENOXOLONE ANTI-ULCER AGENTS CIMETIDINE ... AND RENA BURIMAMIDE HEMATOLOGIC, GASTROINTESTINAL, AND RENA CALCIUM CARBONATE HEMATOLOGIC, GASTROINTESTINAL, AND RENA CALCIUM ... HISTAMINE H1 ANTAGONISTS BURIMAMIDE HISTAMINE H2 ANTAGONISTS CIMETIDINE HISTAMINE H2 ANTAGONISTS FAMOTIDINE HISTAMINE H2 ... HISTAMINE AGENTS BURIMAMIDE HISTAMINE AGENTS BUTYRIC ACID HISTAMINE AGENTS CETIRIZINE HISTAMINE AGENTS CHLORPHENIRAMINE ...
µ
Histamine2
- Starting from the structure of histamine, chemical modification led eventually to burimamide, the first described histamine H2-receptor antagonist. (nih.gov)
- Burimamide competitively antagonized both the histamine‐induced increase in cAMP and the cimetidine‐induced reduction of the basal cAMP level with apparent KB values that were similar to its H2 receptor affinity. (vu.nl)
Receptor3
- Burimamide, a neutral antagonist at the rat H2 receptor, behaved as a weak partial agonist at the human H2 receptor. (vu.nl)
- The partial agonist burimamide induced, like inverse agonists, an upregulation of the human H2 receptor after prolonged treatment. (vu.nl)
- A group led by Adam Black, doing work for the pharmaceutical business Smith Kline and French, uncovered the initial agent that selectively targeted the H2 receptor, burimamide [1]. (cell-signaling-pathways.com)